Kliničke studije za Мигрена u državi Охајо
14 studija za Мигрена traži učesnike na lokacijama u državi Охајо.
Gradovi u državi Охајо
Zvanični tekst studije (na engleskom)
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Ohio State University Wexner Medical Center, Columbus
Тражи се учесникФаза 4
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06972056Study of EVO756 in Adults With Migraine
- NeuroScience Research Center, Canton
- Dayton Center for Neurological Disorders, Centerville
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 13. 11. 2026. · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Velocity Clinical Research, Cleveland, Beachwood
- Velocity Clinical Research, Cincinnati, Blue Ash, Blue Ash
- Headache Center of Hope, Cincinnati
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07816367A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Hometown Research, Columbus
- Hometown Research, Milford
- CincyScience, West Chester
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04649242Overlapping Pain Trajectory Study
- Cincinnati Children's Hospital, Cincinnati
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 10 до 19 · Оба пола · Ажурирано 20. 10. 2026. · NCT05752396Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 10. 2026. · NCT05156398A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center-Burnet Campus, Cincinnati
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 10. 2026. · NCT05164172A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 1
Узраст од 6 до 11 · Оба пола · Ажурирано 28. 9. 2026. · NCT06995729Responding With Evidence and Access for Childhood Headaches
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Childrens, Columbus
Тражи се учесник
Узраст од 10 до 17 · Оба пола · Ажурирано 21. 9. 2026. · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Patient Priority Clinical Sites, LLC /ID# 238485, Cincinnati
- University Of Cincinnati Medical Center /ID# 231199, Cincinnati
- Cincinnati Childrens Hospital Medical Center /ID# 244689, Cincinnati
- и још 3
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 9. 2026. · NCT05125302BE WELL With Migraine: Brain Education and WELLness With Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 12. 6. 2026. · NCT05987592Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #4, Cincinnati
Тражи се учесникФаза 4
Узраст од 6 до 11 · Оба пола · Ажурирано 27. 1. 2025. · NCT04748601Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.